Not sure I agree with your statement. The NEO IND was filed shortly after a deal was struck with Amgen. Striking a deal before the IND allows the partner to influence the terms of the IND and subsequent trials, whereas filing an IND first could limit the indication's parterning interest if potential partners don't agree with the trial path laid out in the IND.
"The HOT IND doesn't seem like some big motivation to make a deal."
News 
Market Data 
Discover 
